Illumina has struggled to boost sales and consistently deliver positive earnings. Its Q4 report was largely a disappointment, and management's 2025 guidance came in below Wall Street's ...

With this earnings history in mind, recent estimates have been moving higher for Illumina. In fact, the Zacks Earnings ESP (Expected Surprise Prediction) for the company is positive, which is a ...

Illumina (ILMN) is expected to deliver a year-over-year increase ... business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ...

Patrick B Donnelly, an analyst from Citi, maintained the Hold rating on Illumina (ILMN – Research Report). The associated price target remains ...

(Reuters) -Shares of genetic testing company Illumina and Calvin Klein-owner PVH Corp fell on Tuesday after China placed the two companies on its "unreliable entity" list, putting them at risk of ...

Illumina is a global leader in developing the ... at improving research tasks such as cell state or gene transcription prediction on a broader scale. At the J.P. Morgan Chase Health Care ...

Illumina's leading sequencing technology ... such as cell state or gene transcription prediction. With this new partnership, the global R&D community can tap into rich genomic data by integrating ...

Shares of Illumina (NASDAQ: ILMN) were falling on Friday. The company's stock was down by as much as 11.4% early in the session, and was still off by 8.7% as of 2:38 p.m. ET. At that time ...

Illumina (ILMN) is expected to deliver a year ... Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.

It was put on a blacklist by the latter country. China's "blacklist of entities" now has two more entries -- Illumina and fashion conglomerate PVH-- after its government put the companies on ...